These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 9299854)
21. Thromboembolic disease--critical evaluation of laboratory investigation. Malm J; Laurell M; Nilsson IM; Dahlbäck B Thromb Haemost; 1992 Jul; 68(1):7-13. PubMed ID: 1514176 [TBL] [Abstract][Full Text] [Related]
22. Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus. Tomás JF; Alberca I; Tabernero MD; Cordero M; Del Pino-Montes J; Vicente V J Rheumatol; 1998 Jan; 25(1):57-62. PubMed ID: 9458203 [TBL] [Abstract][Full Text] [Related]
23. [Evaluation of hemostasis in venous thromboembolism pathology]. Gaussem P; Siguret V; Aiach M Ann Biol Clin (Paris); 1998; 56(1):49-56. PubMed ID: 9754222 [TBL] [Abstract][Full Text] [Related]
24. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206 [TBL] [Abstract][Full Text] [Related]
25. APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee--a prospective study. Lindahl TL; Lundahl TH; Nilsson L; Andersson CA Thromb Haemost; 1999 Jan; 81(1):18-21. PubMed ID: 10348713 [TBL] [Abstract][Full Text] [Related]
26. Hereditary deficiencies of antithrombin III, protein S, and the protein C pathway in Jordanian thrombosis patients. Eid SS Clin Lab Sci; 2002; 15(4):196-9. PubMed ID: 12776777 [TBL] [Abstract][Full Text] [Related]
28. [Prevalence and prevention of venous thromboembolic events in general practice. Multicenter, prospective cohort study]. Pouchain D; Bergmann JF; Bosson JL Rev Prat; 2008 Dec; 58(19 Suppl):3-8. PubMed ID: 19253785 [TBL] [Abstract][Full Text] [Related]
29. Venous thrombosis: prevalence of prothrombotic defects in north Indian population. Bhattacharyya M; Kannan M; Chaudhry VP; Saxena R Indian J Pathol Microbiol; 2003 Oct; 46(4):621-4. PubMed ID: 15025358 [TBL] [Abstract][Full Text] [Related]
30. Familial antithrombin III deficiency. Winter JH; Fenech A; Ridley W; Bennett B; Cumming AM; Mackie M; Douglas AS Q J Med; 1982; 51(204):373-95. PubMed ID: 7156320 [TBL] [Abstract][Full Text] [Related]
31. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects. Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633 [TBL] [Abstract][Full Text] [Related]
32. [Changes in hemostasis system in patients with hereditary thrombophilia caused by mutation of blood coagulation factor V ( factor V Leiden)]. Papaian LP; Kobilianskaia VA; Sheĭdina AM; Baranovskaia SS; Sirotkina OV; Kargin VD; Saltykova NB; Beliazo OE; Golovina OG; Papaian KA; Tarkovskaia LR Ter Arkh; 2001; 73(7):47-51. PubMed ID: 11523408 [TBL] [Abstract][Full Text] [Related]
33. Pathophysiology of thrombophilic states. Mammen EF Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):243-52. PubMed ID: 2465210 [TBL] [Abstract][Full Text] [Related]
34. [Acquired and inherited hypercoagulability among patients with cerebral venous thrombosis]. Sánchez-Martín B; Grasa JM; Latorre A; Montañés MA; García-Erce JA; Torres M; Calvo MT; Giralt M Neurologia; 2002 Oct; 17(8):405-9. PubMed ID: 12396970 [TBL] [Abstract][Full Text] [Related]
35. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin. Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194 [TBL] [Abstract][Full Text] [Related]
36. Incidence and clinical manifestations of activated protein C resistance and factor V Leiden in young patients with venous thromboembolic disease in Spain. Olave T; Cornudella R; Homs C; Azaceta G; Tirado I; Gutierrez M Haematologica; 1998 Apr; 83(4):378-80. PubMed ID: 9592991 [TBL] [Abstract][Full Text] [Related]
37. Is plasminogen deficiency a thrombotic risk factor? A study on 23 thrombophilic patients and their family members. Demarmels Biasiutti F; Sulzer I; Stucki B; Wuillemin WA; Furlan M; Lämmle B Thromb Haemost; 1998 Jul; 80(1):167-70. PubMed ID: 9684804 [TBL] [Abstract][Full Text] [Related]
38. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment. Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB; Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714 [TBL] [Abstract][Full Text] [Related]
39. Inherited Thrombophilia due to Factor V Leiden Mutation. Mattson JC; Crisan D Mol Diagn; 1998 Mar; 3(1):55-61. PubMed ID: 10096958 [TBL] [Abstract][Full Text] [Related]
40. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Hillarp A; Zöller B; Svensson PJ; Dahlbäck B Thromb Haemost; 1997 Sep; 78(3):990-2. PubMed ID: 9308741 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]